Table 3.
Comparison of Overall and Progression-Free Survival between the Two Groups
| Outcome | 18F-FDG PET/CT and Conventional Imaging | Conventional Imaging | Log Rank (p Value) |
|---|---|---|---|
| Overall survival | |||
| Hazard ratio = 0.87 (95% CI: 0.70–1.08) | |||
| Median | 31 mo (26–39) | 23 mos (21–29) | 0.192 |
| 1-y | 79% (74–84) | 82% (77–87) | |
| 2-y | 57% (52–63) | 49% (43–56) | |
| Progression-free survival | |||
| Hazard ratio: 0.87 (95% CI 0.71–1.07) | |||
| Median | 17 mo (14–20) | 14 mo (12–16) | 0.198 |
| 1-y | 61% (56–67) | 58% (52–65) | |
| 2-y | 41% (36–47) | 35% (29–42) | |
18F-FDG PET/CT, fludeoxyglucose F 18 positron emission tomography–computed tomography; CI, confidence interval; NR, not reached.